We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+22.47%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$968M
AUM Growth
+$147M
Cap. Flow
-$19.6M
Cap. Flow %
-2.03%
Top 10 Hldgs %
35.24%
Holding
253
New
24
Increased
29
Reduced
113
Closed
7

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.67M
2
QCOM icon
Qualcomm
QCOM
+$1.95M
3
AMZN icon
Amazon
AMZN
+$1.8M
4
OTIS icon
Otis Worldwide
OTIS
+$1.14M
5
CARR icon
Carrier Global
CARR
+$870K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$5.85M
2
BA icon
Boeing
BA
+$3.28M
3
JPM icon
JPMorgan Chase
JPM
+$2.64M
4
RTX icon
RTX Corp
RTX
+$2.48M
5
AAPL icon
Apple
AAPL
+$1.74M

Sector Composition

Rank Sector Weight
1 Healthcare 20.84%
2 Technology 19.89%
3 Financials 14.13%
4 Industrials 9.95%
5 Communication Services 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MER.PRK
201
Bank of America Income Capital Obligation Notes due December 15 2066
MER.PRK
$1.06B
$207K 0.02%
+8,000
New +$208K
ORI icon
202
Old Republic International
ORI
$10.4B
$191K 0.02%
11,720
– –
MRO
203
DELISTED
Marathon Oil Corporation
MRO
$184K 0.02%
30,136
– –
PBCT
204
DELISTED
People's United Financial Inc
PBCT
$162K 0.02%
14,012
-1,889
-12% -$22K
MFC icon
205
Manulife Financial
MFC
$73.5B
$145K 0.02%
+10,660
New +$134K
PAA icon
206
Plains All American Pipeline
PAA
$16.1B
$141K 0.01%
16,000
– –
NTRP
207
DELISTED
Neurotrope, Inc. Common
NTRP
$127K 0.01%
109,375
– –
WHWK
208
Whitehawk Therapeutics
WHWK
$271M
$125K 0.01%
6,667
– –
NRT
209
North European Oil Royalty Trust
NRT
$81M
$88K 0.01%
27,999
– –
MRKR icon
210
Marker Therapeutics
MRKR
$18.7M
$62K 0.01%
3,010
– –
XCUR icon
211
Exicure
XCUR
$8.54M
$41K ﹤0.01%
111
– –
MTNB icon
212
Matinas BioPharma
MTNB
$1.81M
$14K ﹤0.01%
350
– –
TJX icon
213
TJX Companies
TJX
$178B
– –
-9,370
Closed -$448K
AGN
214
DELISTED
Allergan plc
AGN
– –
-33,012
Closed -$5.85M
RTN
215
DELISTED
Raytheon Company
RTN
– –
-1,664
Closed -$218K
5 6 7 8
9

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q2 2020 Portfolio in Review

As of Q2 2020, Neville Rodie & Shaw held 253 positions worth $968M, up 18% from $821M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Neville Rodie & Shaw's Q2 2020 filing shows 24 new, 29 increased, 113 reduced and 7 closed positions. Its largest new stake was Otis Worldwide: 22,089 shares worth $1.26M. The largest sale was Allergan plc, an estimated $5.85M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

  • Neville Rodie & Shaw's largest Q2 2020 buy was Otis Worldwide: 22,089 shares worth $1.26M.
  • Neville Rodie & Shaw added most to AbbVie in Q2 2020, an estimated $2.67M increase.
  • Neville Rodie & Shaw's biggest Q2 2020 reduction was Boeing, cutting an estimated $3.28M.
  • Neville Rodie & Shaw fully exited Allergan plc in Q2 2020, selling an estimated $5.85M.
  • Neville Rodie & Shaw's ten largest holdings make up 35% of its $968M portfolio in Q2 2020.
  • Neville Rodie & Shaw opened 24 new positions and closed 7 in Q2 2020.
  • Neville Rodie & Shaw's portfolio value rose 18% quarter-over-quarter to $968M.

Based on Neville Rodie & Shaw's 13F filing for Q2 2020, filed 15 Jul 2020.